Two cases of anticholinergic syndrome associated with consumption of bitter lupin flour

Medical Journal of Australia

Volumn 191, Issue 3, 2009, Pages 173-174

  Pingault, Nevada M ^a   Gibbs, Robyn A ^a   Barclay, Alexander M ^b   Monaghan, Mark ^c  

^a DEPARTMENT OF HEALTH   (Australia)

^b Sir Charles Gairdner Hospital ^*

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTICHOLINERGIC SYNDROME; ARTICLE; BLADDER CAPACITY; BLURRED VISION; CASE REPORT; DISEASE ASSOCIATION; DIZZINESS; FEMALE; FLOUR; FOOD ALLERGY; FOOD INTAKE; HUMAN; LETHARGY; LUPIN; MUCOSAL DRYNESS; MYDRIASIS; SINUS TACHYCARDIA; URINE RETENTION; WALKING DIFFICULTY; XEROSTOMIA; CHEMICALLY INDUCED DISORDER; FOOD POISONING; SYNDROME; TACHYCARDIA; VISUAL DISORDER;

ALKALOID; CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGED; ALKALOIDS; CHOLINERGIC ANTAGONISTS; FEMALE; FOOD POISONING; HUMANS; LUPINUS; MYDRIASIS; SYNDROME; TACHYCARDIA; VISION DISORDERS;

EID: 70349564117     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02732.x     Document Type: Article

References (13)

1. Food Standards Australia New Zealand. Australia New Zealand Food Standards Code. Incorporating amendments up to and including amendment 107, Standard 1.4.1: Contaminants and natural toxicants. Canberra: FSANZ, 2009. http://www.foodstandards.gov.au/thecode/foodstandardscode/ (accessed Jun 2009).
2. Hall RS, Thomas SJ, Johnson SK. Australian sweet lupin flour addition reduces the glycaemic index of a white bread breakfast without affecting palatability in healthy human volunteers. Asia Pac J Clin Nutr 2005; 14: 91-97.
3. Lee YP, Mori TA, Sipas S, et al. Lupin-enriched bread increases satiety and reduces energy intake acutely. Am J Clin Nutr 2006; 84: 975-980.
4. Archer BJ, Johnson SK, Devereux HM, et al. Effect of fat replacement by inulin or lupin-kernal fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men. Br J Nutr 2004; 91: 591-599.
5. Shaw J, Roberts G, Grimshaw K, et al. Lupin allergy in peanut-allergic children and teenagers. Allergy 2008; 63: 370-373. (Pubitemid 351224675)
6. Peeters KABM, Nordlee JA, Penninks AH, et al. Lupine allergy: not simply cross-reactivity with peanut or soy. J Allergy Clin Immunol 2007; 120: 647-653.
7. Australia New Zealand Food Authority. Lupin alkaloids in food. A toxicological review and risk assessment. Technical report series no. 3. Canberra: ANZFA, 2001. http://www.foodstandards.gov.au/-srcfiles/TR3.pdf (accessed Jun 2009).
8. Burkhart KK. The anticholinergic patient. In: Dart RC, Caravati EM, McGuigan MA, et al, editors. Medical toxicology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2004: 51-53.
9. Kurzbaum A, Safori G, Monir M, et al. Anticholinergic syndrome in response to lupin seed toxicity. Isr J Emerg Med 2008; 8: 20-22.
10. Di Grande A, Paradiso R, Amico S, et al. Anticholinergic toxicity associated with lupin seed ingestion: case report. Eur J Emerg Med 2004; 11: 119-120.
11. Tsiodras S, Shin RK, Christian M, et al. Anticholinergic toxicity associated with lupine seeds as a home remedy for diabetes mellitus. Ann Emerg Med 1999; 33: 715-717. (Pubitemid 29254743)
12. Litkey J, Dailey MW. Anticholinergic toxicity associated with the ingestion of lupini beans. Am J Emerg Med 2007; 25: 215-217. (Pubitemid 46185840)
13. Lowen RJ, Alam FKA, Edgar JA. Lupin bean toxicity. Med J Aust 1995; 162: 256-257.